Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients

Back

ESC Premium Access

Effect of sodium glucose cotransporter 2 inhibitor on sympathetic nerve activity in type 2 diabetes mellitus patients

Session: Challenges in hypertension treatment

Topic: Renal and Renovascular Hypertension

Speaker: Doctor T. Hamaoka (Kanazawa, JP)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Takuto Hamaoka

Kanazawa University Hospital, Kanazawa (Japan)

0 follower

9 more presentations in this session

Dose antihypertensive medication improve accelerated age-dependent decline of GFR in hypertension?

Speaker: Doctor H. Takase (Hamamatsu, JP)

Combined therapy of empagliflozin and linagliptin is superior to metformin and insulin glargine in improving blood pressure and vascular function in type 2 diabetes

Speaker: Miss S. Jung (Erlangen, DE)

Adverse effects of spironolactone in long-term treatment of resistant arterial hypertension

Speaker: Associate Professor J. Vaclavik (Ostrava, CZ)

The administration of an aldosterone antagonist as the second step of treatment improves efficacy and adherence at all hypertensive levels

Speaker: Doctor V. Martire (La Plata, AR)

Access

Peripheral edema and headache associated with amlodipine treatment: a meta-analysis of randomized, placebo-controlled trials

Speaker: Doctor D. Vukadinovic (Homburg, DE)

Access the full session

Challenges in hypertension treatment

Speakers: Doctor T. Hamaoka, Doctor H. Takase, Miss S. Jung, Associate Professor J. Vaclavik, Doctor V. Martire...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources